Effect of Combined Intravenous Immunoglobulin and Mycophenolate Mofetil in a Pediatric Patient With Highly Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

참고문헌 (8)

1. Cobo-Calvo A, "Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease", Ann Neurol, 89, pp.30~41 (2021)
2. Bruijstens AL, "E. U. paediatric MOG consortium consensus : part 5-Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders", Eur J Paediatr Neurol, 29, pp.41~53 (2020)
3. Kim Y, "Refining cell-based assay to detect MOG-IgG in patients with central nervous system inflammatory diseases", Mult Scler Relat Disord, 40, pp.101939~ (2020)
4. Hacohen Y, "Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease", JAMA Neurol, 75, pp.478~487 (2018)
5. Chen JJ, "Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder", Neurology, 95, pp.e111~e120 (2020)
6. Deshmukh CT, "Minimizing side effects of systemic corticosteroids in children", Indian J Dermatol Venereol Leprol, 73, pp.218~221 (2007)
7. Sharma KG, "Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction", Transpl Immunol, 23, pp.117~120 (2010)
8. Danieli MG, "Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis", Autoimmun Rev, 9, pp.124~127 (2009)

관련 논문AI추천